MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
18.20
-0.48 (-2.57%)
At close: Feb 24, 2026, 4:00 PM EST
18.23
+0.03 (0.16%)
After-hours: Feb 24, 2026, 7:56 PM EST
MLTX Employees
MoonLake Immunotherapeutics had 100 employees as of December 31, 2024. The number of employees increased by 50 or 100.00% compared to the previous year.
Employees
100
Change (1Y)
50
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$2,104,955
Market Cap
1.30B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 100 | 50 | 100.00% |
| Dec 31, 2023 | 50 | 30 | 150.00% |
| Dec 31, 2022 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 645 |
| Vir Biotechnology | 408 |
| Geron | 229 |
| Day One Biopharmaceuticals | 184 |
| Zenas BioPharma | 130 |
| DBV Technologies | 117 |
| ORIC Pharmaceuticals | 106 |
| Nanobiotix | 103 |
MLTX News
- 8 hours ago - MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal - Seeking Alpha
- 1 day ago - MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript - Seeking Alpha
- 1 day ago - MoonLake Immunotherapeutics Data Shows Phase 2 Success For Chronic Back Pain - Benzinga
- 14 days ago - ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer - GlobeNewsWire
- 22 days ago - MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day - GlobeNewsWire
- 4 weeks ago - Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares - GlobeNewsWire
- 4 weeks ago - Helix Acquisition Corp. III Announces Pricing of Upsized $150 Million Initial Public Offering - GlobeNewsWire
- 6 weeks ago - MoonLake: Positive FDA Meeting Spurs Momentum Ahead Of BLA Submission - Seeking Alpha